Latest Company Funding News

Page 2 of 5
icetana AI returned to revenue growth in FY26, with sales up 31% to $2.47 million and annual recurring revenue reaching $2.6 million. The company remains loss-making, but entered FY27 with stronger recurring revenue, new distribution channels and $4.79 million in cash.
Sophie Babbage
Sophie Babbage
27 Oct 2026
Actinogen Medical has received an A$10.84 million R&D tax rebate, leaving it with A$21.9 million in pro forma cash and no debt just weeks before its pivotal Alzheimer’s readout. The company says topline XanaMIA results remain due in mid-November.
Ada Torres
Ada Torres
26 Oct 2026
Ora Banda Mining (ASX:OBM) kept its FY27 guidance intact despite weather disruption and an extended mill shutdown lifting quarterly AISC to A$4,214 an ounce. The company is spending heavily to build its next production phase, with the new 3.0 Mtpa plant on schedule and Waihi Underground starting ahead of plan.
Maxwell Dee
Maxwell Dee
23 Oct 2026
Amplia Therapeutics has received an A$4.78 million refundable R&D tax rebate, giving the clinical-stage biotechnology company additional cash to advance its FAK inhibitor programs. The funds will support multiple narmafotinib trials and related research, including studies involving Lilly.
Victor Sage
Victor Sage
22 Oct 2026
PARKD has completed an A$800,000 placement to strategic investors, issuing 22.86 million new shares at 3.5 cents each. The capital raise is now settled, but existing shareholders face dilution as the company funds its next phase of expansion.
Victor Sage
Victor Sage
21 Oct 2026
Orthocell says Remplir was placed successfully in five complex robotic prostatectomy cases, with no device-related complications reported over approximately 12 months. The preliminary results will guide a larger prospective trial ahead of a planned US expansion for the nerve repair product.
Ada Torres
Ada Torres
13 Oct 2026
Sports Entertainment Group has completed the second tranche of its institutional placement, raising a further A$4.75 million at A$0.28 per share. The top-up takes total placement proceeds to about A$14.54 million before costs as the company funds its MediaWorks transaction.
Victor Sage
Victor Sage
12 Oct 2026
Australian Ethical Investment delivered record funds under management and a 29% rise in shareholder profit in FY26, despite weak performance from Australian equities and emerging companies. The ASX-listed ethical fund manager also increased its fully franked dividend and set out a growth plan centred on private markets, superannuation and technology.
Claire Turing
Claire Turing
9 Oct 2026
Dome Gold Mines says its audited financial report for the year ended 30 June 2026 remains unfinished, with release now pending a proposed capital raising announcement and Fiji project valuation report. The company has not provided a revised release date or details of the fundraising.
Maxwell Dee
Maxwell Dee
1 Oct 2026
Golden Deeps has reported high-grade polymetallic results at its Graceland prospect in Namibia while stepping up deeper drilling across an 800-metre target corridor. The explorer ended FY2026 with $4.218 million in cash, but remains dependent on exploration success and future funding.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.
Victor Sage
Victor Sage
30 Sept 2026
Macquarie Global Small Companies Fund reported a A$561,000 operating profit in its first financial period after launching three unit classes in June. The fund ended the period with A$11.757 million in net assets, although its short start-up period offers little basis for judging full-year performance.
Claire Turing
Claire Turing
30 Sept 2026

Browse the archive

Full archive